| Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection KA Brown, N Khanafer, N Daneman, DN Fisman Antimicrobial agents and chemotherapy 57 (5), 2326-2332, 2013 | 736 | 2013 |
| Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes SA Buchan, H Chung, KA Brown, PC Austin, DB Fell, JB Gubbay, ... JAMA network open 5 (9), e2232760-e2232760, 2022 | 400 | 2022 |
| Estimates of SARS-CoV-2 omicron variant severity in Ontario, Canada AC Ulloa, SA Buchan, N Daneman, KA Brown JAMA 327 (13), 1286-1288, 2022 | 388 | 2022 |
| Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction L Lambert, K Brown, E Segal, J Brophy, J Rodes-Cabau, P Bogaty JAMA 303 (21), 2148-2155, 2010 | 380 | 2010 |
| Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study H Chung, S He, S Nasreen, M Sundaram, S Buchan, S Wilson, B Chen, ... BMJ, 2021 | 377 | 2021 |
| For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths NM Stall, A Jones, KA Brown, PA Rochon, AP Costa Cmaj 192 (33), E946-E955, 2020 | 299 | 2020 |
| Association between nursing home crowding and COVID-19 infection and mortality in Ontario, Canada KA Brown, A Jones, N Daneman, AK Chan, KL Schwartz, GE Garber, ... JAMA internal medicine 181 (2), 229-236, 2021 | 287 | 2021 |
| Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario S Nasreen, H Chung, S He, KA Brown, JB Gubbay, SA Buchan, DB Fell, ... Nature microbiology 7 (3), 379-385, 2022 | 282 | 2022 |
| Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada S Nasreen, H Chung, S He, KA Brown, JB Gubbay, SA Buchan, DB Fell, ... Medrxiv, 2021.06. 28.21259420, 2021 | 232 | 2021 |
| Comparative effectiveness of vancomycin and metronidazole for the prevention of recurrence and death in patients with Clostridium difficile infection VW Stevens, RE Nelson, EM Schwab-Daugherty, K Khader, MM Jones, ... JAMA internal medicine 177 (4), 546-553, 2017 | 206 | 2017 |
| Association of age and pediatric household transmission of SARS-CoV-2 infection LA Paul, N Daneman, KL Schwartz, KA Brown, M Whelan, E Chan, ... JAMA pediatrics 175 (11), 1151-1158, 2021 | 193 | 2021 |
| Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities—United States RB Slayton, D Toth, BY Lee, W Tanner, SM Bartsch, K Khader, K Wong, ... MMWR. Morbidity and mortality weekly report 64 (30), 826-831, 2015 | 185 | 2015 |
| Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection KA Brown, K Valenta, D Fisman, A Simor, N Daneman JAMA internal medicine 175 (4), 626-633, 2015 | 175 | 2015 |
| Evaluation of Care and Surveillance of Cardiovascular Disease: Can We Trust Medico-administrative Hospital Data? L Lambert, C Blais, D Hamel, K Brown, S Rinfret, R Cartier, M Giguère, ... Canadian Journal of Cardiology, 2012 | 151 | 2012 |
| S-gene target failure as a marker of variant B. 1.1. 7 among SARS-CoV-2 isolates in the greater Toronto area, December 2020 to March 2021 KA Brown, J Gubbay, J Hopkins, S Patel, SA Buchan, N Daneman, ... JAMA 325 (20), 2115-2116, 2021 | 148 | 2021 |
| Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study M Verway, KA Brown, A Marchand-Austin, C Diong, S Lee, B Langford, ... Journal of Clinical Microbiology 60 (4), e02429-21, 2022 | 144 | 2022 |
| Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis J Curran, J Lo, V Leung, K Brown, KL Schwartz, N Daneman, G Garber, ... Clinical Microbiology and Infection 28 (4), 479-490, 2022 | 126 | 2022 |
| Antibiotic Prescribing Choices and Their Comparative C. Difficile Infection Risks: A Longitudinal Case-Cohort Study KA Brown, B Langford, KL Schwartz, C Diong, G Garber, N Daneman Clinical Infectious Diseases 72 (5), 836-844, 2021 | 114 | 2021 |
| Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006–2010 BE Jones, MM Jones, B Huttner, G Stoddard, KA Brown, VW Stevens, ... Clinical Infectious Diseases 61 (9), 1403-1410, 2015 | 104 | 2015 |
| The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study KA Brown, DN Fisman, R Moineddin, N Daneman PLoS ONE 9 (8), e105454, 2014 | 102 | 2014 |
Nick DanemanClinician Scientist, Sunnybrook Health Sciences Centre, University of TorontoVerified email at sunnybrook.ca
